Samtidig behandling med andre liposomale eller lipidkomplekse stoffer eller intravenøse fedtemulsioner kan muligvis ændre Myocets farmakokinetiske profil.
Concomitant therapy with other liposomal or lipid-complexed substances or intravenous fat emulsions could change the pharmacokinetic profile of Myocet.